Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Somatostatin Receptor”

136 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 136 results

Not applicableStudy completedNCT01879657
What this trial is testing

68Ga-DOTATATE PET-CT for Diagnosis of Neuroendocrine Tumors (NETs)

Who this might be right for
Neuroendocrine Carcinoma
Radio Isotope Therapy of America 169
Testing effectiveness (Phase 2)Study completedNCT02162446
What this trial is testing

68Ga-OPS202 Study for Diagnostic Imaging of GEP NET

Who this might be right for
Gastroenteropancreatic Neuroendocrine Tumors
Ipsen 12
Not applicableNo Longer AvailableNCT01980732
What this trial is testing

68Ga DOTA-TATE PET/CT in Somatostatin Receptor Positive Tumors

Who this might be right for
Carcinoid TumorsIslet Cell (Pancreatic NET)Other Neuroendocrine Tumors
Andrei Iagaru
Early research (Phase 1)Looking for participantsNCT07413042
What this trial is testing

A Phase I Study to Evaluate the Safety and Preliminary Efficacy of [225Ac]Ac-DOTATATE Injection Combined With Tislelizumab in the Maintenance Treatment Period for Patients of Extensive-stage Small Cell Lung Cancer (ES-SCLC) With Somatostatin Receptors (SSTR)+ as First-line Treatment

Who this might be right for
SCLC, Extensive Stage
Peking University Cancer Hospital & Institute 24
Testing effectiveness (Phase 2)Study completedNCT01237457
What this trial is testing

177Lutetium-DOTA-Octreotate Therapy in Somatostatin Receptor-Expressing Neuroendocrine Neoplasms

Who this might be right for
Neuroendocrine Tumors
Ebrahim S Delpassand 143
Large-scale testing (Phase 3)Active Not RecruitingNCT05459844
What this trial is testing

A Study Comparing Treatment With Lutetium[177Lu] Oxodotreotide Injection to Octreotide LAR in Patients With GEP-NETs

Who this might be right for
Neuroendocrine Tumors
Sinotau Pharmaceutical Group 196
Not applicableApproved For MarketingNCT04334837
What this trial is testing

Copper Cu 64 Dotatate for the Detection, Localization and Monitoring of SSTR Expressing (NETs)

Who this might be right for
Neuroendocrine Tumors
Curium US LLC
Large-scale testing (Phase 3)Looking for participantsNCT05884255
What this trial is testing

An Open-label Phase 3 Study of Lutetium (177Lu) Oxodotreotide Injection in Subjects With Advanced Gastrointestinal Pancreatic Neuroendocrine Tumors.

Who this might be right for
Advanced Gastroenteropancreatic Neuroendocrine Tumor
Jiangsu HengRui Medicine Co., Ltd. 220
Testing effectiveness (Phase 2)Active Not RecruitingNCT04711135
What this trial is testing

Study to Evaluate Safety and Dosimetry of Lutathera in Adolescent Patients With GEP-NETs and PPGLs

Who this might be right for
Gastroenteropancreatic Neuroendocrine TumorsPheochromocytomaParaganglioma
Advanced Accelerator Applications 11
Not applicableStudy completedNCT06255249
What this trial is testing

Multicenter Evaluation in Patients With MEningiomas of the Response to Treatment With 177LUTEtium-oxodotreotide

Who this might be right for
Meningioma
Central Hospital, Nancy, France 50
Not applicableStudy completedNCT04069299
What this trial is testing

Use of 68Ga-dotatate PET Scan in Neuroendocrine Carcinoma of the GI Tract

Who this might be right for
Neuroendocrine Carcinoma
H. Lee Moffitt Cancer Center and Research Institute 30
Not applicableNot Yet RecruitingNCT07538791
What this trial is testing

Italian Multicenter Experience With Radioreceptor-assisted Therapy (PRRT)

Who this might be right for
PheochromocytomasParagangliomas
Azienda USL Reggio Emilia - IRCCS 210
Early research (Phase 1)Ended earlyNCT00002947
What this trial is testing

Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer

Who this might be right for
Brain and Central Nervous System TumorsChildhood Langerhans Cell HistiocytosisGastrointestinal Carcinoid Tumor+9 more
Yale University 35
Early research (Phase 1)Study completedNCT03966651
What this trial is testing

A Clinical Study Evaluating the Safety of Peptide Receptor Radionuclide Therapy (PRRT) With 177Lu-DOTA0-Tyr3-Octreotate in Children With Refractory or Recurrent Neuroblastoma Expressing Somatostatin Receptors.

Who this might be right for
Neuroblastoma
Institut Claudius Regaud 1
Large-scale testing (Phase 3)Looking for participantsNCT05918302
What this trial is testing

Efficacy and Safety of Radiotherapy Compared to Everolimus in Somatostatin Receptor Positive Neuroendocrine Tumors of the Lung and Thymus.

Who this might be right for
Neuroendocrine TumorsLung Neuroendocrine NeoplasmThymus Neoplasms
Grupo Espanol de Tumores Neuroendocrinos 170
Testing effectiveness (Phase 2)UnknownNCT02236910
What this trial is testing

An Open Label Registry Study of Lutetium-177 (DOTA0, TYR3) Octreotate (Lu-DOTA-TATE) Treatment in Patients with Somatostatin Receptor Positive Tumours

Who this might be right for
Neuroendocrine Carcinoma
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 66
Not applicableLooking for participantsNCT06690957
What this trial is testing

Somatostatin Receptor PET/CT in SSTR-Related Disease Patients

Who this might be right for
SSTR-related DiseaseTumorPositron Emission Tomography+1 more
Tianjin Medical University 500
Early research (Phase 1)Study completedNCT00006368
What this trial is testing

Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer

Who this might be right for
Brain and Central Nervous System TumorsBreast CancerGastrointestinal Carcinoid Tumor+5 more
Novartis Pharmaceuticals 60
Testing effectiveness (Phase 2)Looking for participantsNCT05278208
What this trial is testing

Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors

Who this might be right for
High Grade GliomaMeningiomaEmbryonal Tumor+10 more
Nationwide Children's Hospital 65
Testing effectiveness (Phase 2)Ended earlyNCT07037420
What this trial is testing

ALXN2420 Versus Placebo in Combination With Somatostatin Analogs in Participants With Acromegaly

Who this might be right for
Acromegaly
Alexion Pharmaceuticals, Inc. 8
Next Page